July 22,1999 Mr. Daniel M. Bell President and Chief Executive Officer Kos Pharmaceuticals, Inc. 1001 Brickell Bay Drive, 25th Floor Miami, FL 33131 Re: CO-PROMOTION COLLABORATION -------------------------- Dear Mr. Bell: This letter sets forth terms...Kos Pharmaceuticals Inc • November 12th, 1999 • Pharmaceutical preparations • New Jersey
RECITALSEmployment Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
WITNESSETHLease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc • Florida
Exhibit 10.1 EMPLOYMENT AGREEMENT This Agreement (this "Agreement"), dated as of April 26, 2001, is entered into between Kos Pharmaceuticals, Inc., a Florida corporation (the "Company"), and Adrian Adams (the "Executive").Employment Agreement • November 21st, 2001 • Kos Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.27 WARRANT AGREEMENT This WARRANT AGREEMENT is dated and entered into as of January 1, 2002, by and between KOS PHARMACEUTICALS, INC., a Florida corporation (the "Company"), and PHARMABIO DEVELOPMENT INC., a North Carolina corporation...Warrant Agreement • March 29th, 2002 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
EXHIBIT 10.2 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of May 3, 2000 (this "Agreement"), between Kos Pharmaceuticals, Inc., a Florida corporation (the "Company"), and DuPont Pharmaceuticals Company, a Delaware general...Stock Purchase Agreement • August 10th, 2000 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
RECITALSEmployment Agreement • September 2nd, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations
COMMON STOCK (PAR VALUE $.01 PER SHARE)Underwriting Agreement • November 20th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSSupply Agreement • November 4th, 2002 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 2.1 CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. PRODUCT ACQUISITION AGREEMENT BY AND BETWEEN AVENTIS PHARMACEUTICALS HOLDINGS INC.Kos Pharmaceuticals Inc • March 26th, 2004 • Pharmaceutical preparations • New York
EXHIBIT 10.20 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAW. NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF NOR ANY INTEREST...Kos Pharmaceuticals Inc • March 23rd, 2000 • Pharmaceutical preparations • Florida
RECITALSEmployment Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
WITNESSETHLease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc • Florida
SECURITY AGREEMENT This Security Agreement dated September 1, 1999, by and between KOS PHARMACEUTICALS, INC., a Florida corporation having a principal place of business at 1001 Brickell Bay Drive, 25th Floor, Miami, FL 33131 (hereinafter called the...Security Agreement • November 12th, 1999 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
BACKGROUND:Master Services Agreement • March 29th, 2002 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSLicense Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
EXHIBIT 10.22 SECOND AMENDED AND RESTATED SECURITY AGREEMENT This Second Amended and Restated Security Agreement dated as of December 19, 2002, by and between KOS PHARMACEUTICALS, INC., a Florida corporation having a principal place of business at...Security Agreement • March 26th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSRegistration Rights Agreement • March 23rd, 2000 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. OPTION/LICENSE AGREEMENT THIS AGREEMENT is made by and between Kos Pharmaceuticals, Inc., a corporation of the State of...License Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
50,000,000.00 New York, New York December 21, 1999 1. OBLIGATION TO PAY FOR VALUE RECEIVED, the undersigned Borrower promises to pay to the order of MICHAEL JAHARIS, an individual residing in South Norwalk, Connecticut (the "Lender"), the principal...Kos Pharmaceuticals Inc • March 23rd, 2000 • Pharmaceutical preparations • Connecticut
30,000,000.00 New York, New York December 19, 2002 1. OBLIGATION TO PAY FOR VALUE RECEIVED, the undersigned Borrower promises to pay to the order of MICHAEL JAHARIS, an individual residing in New York, New York (the "Lender"), the principal sum of...Kos Pharmaceuticals Inc • March 26th, 2003 • Pharmaceutical preparations
EXHIBIT 10.18 AMENDED AND RESTATED SECURITY AGREEMENT This Amended and Restated Security Agreement dated as of December 21, 1999, by and between KOS PHARMACEUTICALS, INC., a Florida corporation having a principal place of business at 1001 Brickell Bay...Security Agreement • March 23rd, 2000 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
DEFINITIONSCredit and Loan Agreement • March 23rd, 2000 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
April 27, 1998 COMMITMENT LETTERKos Pharmaceuticals Inc • May 14th, 1998 • Pharmaceutical preparations • Connecticut
RECITALSModification and Extension Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This Amended and Restated Registration Rights Agreement (this "Agreement") is made and entered into effective as of September 1, 1999, by and between Kos Pharmaceuticals, Inc., a Florida corporation...Registration Rights Agreement • November 12th, 1999 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EXHIBIT 10.6 KOS PHARMACEUTICALS, INC. NONQUALIFIED STOCK OPTION AGREEMENT This Nonqualified Stock Option Agreement (the "Agreement"), effective as of June 20, 1996, is made by and between Kos Pharmaceuticals, Inc., a Florida corporation (the...Nonqualified Stock Option Agreement • September 2nd, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. DEVELOPMENT AGREEMENT THIS AGREEMENT is made by and between Kos Pharmaceuticals, Inc., a corporation of the State of...Development Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. OPTION/LICENSE AGREEMENT THIS AGREEMENT is made by and between Kos Pharmaceuticals, Inc., a corporation of the State of...License Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER among ABBOTT LABORATORIES, S&G NUTRITIONALS, INC. and KOS PHARMACEUTICALS, INC. Dated as of November 5, 2006Agreement and Plan of Merger • November 7th, 2006 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER, dated as of November 5, 2006 (this “Agreement”) among ABBOTT LABORATORIES, an Illinois corporation (“Parent”), S&G Nutritionals, Inc., a Delaware corporation and a direct wholly-owned Subsidiary of Parent (“Merger Sub”), and KOS PHARMACEUTICALS, INC., a Florida corporation (the “Company”).
EXHIBIT 10.2 KOS PHARMACEUTICALS, INC. NONQUALIFIED STOCK OPTION AGREEMENT This Nonqualified Stock Option Agreement (the "Agreement"), effective as of June 20, 1996, is made by and between Kos Pharmaceuticals, Inc., a Florida corporation (the...Nonqualified Stock Option Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
RECITALSRegistration Rights Agreement • March 26th, 2003 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Florida
WITNESSETH:Modification of Lease Agreement • December 17th, 1996 • Kos Pharmaceuticals Inc
EXHIBIT 10.26 CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. INVESTMENT AND ROYALTY AGREEMENT This Investment and Royalty Agreement (this "Agreement") is made as of...Investment and Royalty Agreement • March 29th, 2002 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • New York
